Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses

Stem Cell Reports

Volumn 5, Issue 3, 2015, Pages 392-404

  Wang, Wei Bei ^a   Yen, Men Luh ^b   Liu, Ko Jiunn ^c,d   Hsu, Pei Ju ^a   Lin, Ming Hong ^e   Chen, Pei Min ^b   Sudhir, Putty Reddy ^f   Chen, Chein Hung ^f   Chen, Chung Hsuan ^f   Sytwu, Huei Kang ^e   Yen, B Linju ^a,g  

^a National Health Research Institutes (NHRI)   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

^g CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 25; PROGRAMMED DEATH 1 LIGAND 1; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; CD274 PROTEIN, HUMAN; IL25 PROTEIN, HUMAN; INTERLEUKIN 17; STAT3 PROTEIN, HUMAN;

ARTICLE; CELL INTERACTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; UPREGULATION; CYTOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY;

ANTIGENS, CD274; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-17; MESENCHYMAL STROMAL CELLS; STAT3 TRANSCRIPTION FACTOR; TH17 CELLS; TRANSCRIPTION, GENETIC;

EID: 84941184783     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2015.07.013     Document Type: Article

References (64)

1. S. Aggarwal, and M.F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood 105 2005 1815 1822
2. A.E. Aksu, E. Horibe, J. Sacks, R. Ikeguchi, J. Breitinger, M. Scozio, J. Unadkat, and M. Feili-Hariri Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats Clin. Immunol. 127 2008 348 358
3. F. Annunziato, L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Filì, S. Ferri, F. Frosali, and et al. Phenotypic and functional features of human Th17 cells J. Exp. Med. 204 2007 1849 1861
4. M.A. Antonysamy, W.C. Fanslow, F. Fu, W. Li, S. Qian, A.B. Troutt, and A.W. Thomson Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors J. Immunol. 162 1999 577 584
5. A. Bartholomew, C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, S. Patil, W. Hardy, S. Devine, D. Ucker, R. Deans, and et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo Exp. Hematol. 30 2002 42 48
6. E.J. Bassi, P.M. Moraes-Vieira, C.S. Moreira-Sá, D.C. Almeida, L.M. Vieira, C.S. Cunha, M.I. Hiyane, A.S. Basso, A. Pacheco-Silva, and N.O. Câmara Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes Diabetes 61 2012 2534 2545
7. J.A. Brown, D.M. Dorfman, F.R. Ma, E.L. Sullivan, O. Munoz, C.R. Wood, E.A. Greenfield, and G.J. Freeman Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production J. Immunol. 170 2003 1257 1266
8. A.I. Caplan, and D. Correa The MSC: An injury drugstore Cell Stem Cell 9 2011 11 15
9. R. Caruso, M. Sarra, C. Stolfi, A. Rizzo, D. Fina, M.C. Fantini, F. Pallone, T.T. MacDonald, and G. Monteleone Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut Gastroenterology 136 2009 2270 2279
10. R. Caruso, C. Stolfi, M. Sarra, A. Rizzo, M.C. Fantini, F. Pallone, T.T. MacDonald, and G. Monteleone Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 Blood 113 2009 3512 3519
11. C.J. Chang, M.L. Yen, Y.C. Chen, C.C. Chien, H.I. Huang, C.H. Bai, and B.L. Yen Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma Stem Cells 24 2006 2466 2477
12. W.C. Chang, C.K. Chou, C.C. Tsou, S.H. Li, C.H. Chen, Y.X. Zhuo, W.L. Hsu, and C.H. Chen Comparative proteomic analysis of proteins involved in the tumorigenic process of seminal vesicle carcinoma in transgenic mice Int. J. Proteomics 2010 2010 726968
13. P.M. Chen, M.L. Yen, K.J. Liu, H.K. Sytwu, and B.L. Yen Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells J. Biomed. Sci. 18 2011 49 59
14. P.J. Darlington, M.N. Boivin, C. Renoux, M. François, J. Galipeau, M.S. Freedman, H.L. Atkins, J.A. Cohen, L. Solchaga, and A. Bar-Or Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis Ann. Neurol. 68 2010 540 545
15. M. Di Nicola, C. Carlo-Stella, M. Magni, M. Milanesi, P.D. Longoni, P. Matteucci, S. Grisanti, and A.M. Gianni Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli Blood 99 2002 3838 3843
16. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, Dj. Prockop, and E. Horwitz Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy 8 2006 315 317
17. C. Dong TH17 cells in development: An updated view of their molecular identity and genetic programming Nat. Rev. Immunol. 8 2008 337 348
18. N. Eliopoulos, J. Stagg, L. Lejeune, S. Pommey, and J. Galipeau Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice Blood 106 2005 4057 4065
19. A.J. Engler, S. Sen, H.L. Sweeney, and D.E. Discher Matrix elasticity directs stem cell lineage specification Cell 126 2006 677 689
20. A. Erices, P. Conget, and J.J. Minguell Mesenchymal progenitor cells in human umbilical cord blood Br. J. Haematol. 109 2000 235 242
21. P.G. Fallon, S.J. Ballantyne, N.E. Mangan, J.L. Barlow, A. Dasvarma, D.R. Hewett, A. McIlgorm, H.E. Jolin, and A.N. McKenzie Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion J. Exp. Med. 203 2006 1105 1116
22. S.M. Faust, G. Lu, B.L. Marini, W. Zou, D. Gordon, Y. Iwakura, Y. Laouar, and D.K. Bishop Role of T cell TGFbeta signaling and IL-17 in allograft acceptance and fibrosis associated with chronic rejection J. Immunol. 183 2009 7297 7306
23. A.J. Friedenstein Precursor cells of mechanocytes Int. Rev. Cytol. 47 1976 327 359
24. S. Furuta, Y.M. Jeng, L. Zhou, L. Huang, I. Kuhn, M.J. Bissell, and W.H. Lee IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells Sci. Transl. Med. 3 2011 78ra31
25. A. Gebler, O. Zabel, and B. Seliger The immunomodulatory capacity of mesenchymal stem cells Trends Mol. Med. 18 2012 128 134
26. S. Ghannam, J. Pène, G. Moquet-Torcy, C. Jorgensen, and H. Yssel Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype J. Immunol. 185 2010 302 312
27. A. Giordano, U. Galderisi, and I.R. Marino From the laboratory bench to the patient's bedside: An update on clinical trials with mesenchymal stem cells J. Cell. Physiol. 211 2007 27 35
28. M.A. González, E. Gonzalez-Rey, L. Rico, D. Büscher, and M. Delgado Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells Arthritis Rheum. 60 2009 1006 1019
29. J.M. Hare, J.E. Fishman, G. Gerstenblith, D.L. DiFede Velazquez, J.P. Zambrano, V.Y. Suncion, M. Tracy, E. Ghersin, P.V. Johnston, J.A. Brinker, and et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial JAMA 308 2012 2369 2379
30. K. Hirahara, K. Ghoreschi, X.P. Yang, H. Takahashi, A. Laurence, G. Vahedi, G. Sciumè, A.O. Hall, C.D. Dupont, L.M. Francisco, and et al. Interleukin-27 priming of T cells controls IL-17 production in trans via induction of the ligand PD-L1 Immunity 36 2012 1017 1030
31. Y. Iwakura, H. Ishigame, S. Saijo, and S. Nakae Functional specialization of interleukin-17 family members Immunity 34 2011 149 162
32. M.E. Keir, M.J. Butte, G.J. Freeman, and A.H. Sharpe PD-1 and its ligands in tolerance and immunity Annu. Rev. Immunol. 26 2008 677 704
33. M.R. Kim, R. Manoukian, R. Yeh, S.M. Silbiger, D.M. Danilenko, S. Scully, J. Sun, M.L. DeRose, M. Stolina, D. Chang, and et al. Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production Blood 100 2002 2330 2340
34. N. Kim, K.I. Im, J.Y. Lim, E.J. Jeon, Y.S. Nam, E.J. Kim, and S.G. Cho Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: Experiments and practice Ann. Hematol. 92 2013 1295 1308
35. M.A. Kleinschek, A.M. Owyang, B. Joyce-Shaikh, C.L. Langrish, Y. Chen, D.M. Gorman, W.M. Blumenschein, T. McClanahan, F. Brombacher, S.D. Hurst, and et al. IL-25 regulates Th17 function in autoimmune inflammation J. Exp. Med. 204 2007 161 170
36. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 Cells Annu. Rev. Immunol. 27 2009 485 517
37. K. Le Blanc, and D. Mougiakakos Multipotent mesenchymal stromal cells and the innate immune system Nat. Rev. Immunol. 12 2012 383 396
38. K. Le Blanc, F. Frassoni, L. Ball, F. Locatelli, H. Roelofs, I. Lewis, E. Lanino, B. Sundberg, M.E. Bernardo, M. Remberger, et al. Developmental Committee of the European Group for Blood and Marrow Transplantation Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study Lancet 371 2008 1579 1586
39. J. Lee, W.H. Ho, M. Maruoka, R.T. Corpuz, D.T. Baldwin, J.S. Foster, A.D. Goddard, D.G. Yansura, R.L. Vandlen, W.I. Wood, and A.L. Gurney IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1 J. Biol. Chem. 276 2001 1660 1664
40. E.R. Lutz, A.A. Wu, E. Bigelow, R. Sharma, G. Mo, K. Soares, S. Solt, A. Dorman, A. Wamwea, A. Yager, and et al. Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation Cancer Immunol. Res. 2 2014 616 631
41. P. Luz-Crawford, D. Noël, X. Fernandez, M. Khoury, F. Figueroa, F. Carrión, C. Jorgensen, and F. Djouad Mesenchymal stem cells repress Th17 molecular program through the PD-1 pathway PLoS ONE 7 2012 e45272
42. R. Maccario, M. Podestà, A. Moretta, A. Cometa, P. Comoli, D. Montagna, L. Daudt, A. Ibatici, G. Piaggio, S. Pozzi, and et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype Haematologica 90 2005 516 525
43. P. Miossec, and J.K. Kolls Targeting IL-17 and TH17 cells in chronic inflammation Nat. Rev. Drug Discov. 11 2012 763 776
44. G. Monteleone, F. Pallone, and T.T. Macdonald Interleukin-25: A two-edged sword in the control of immune-inflammatory responses Cytokine Growth Factor Rev. 21 2010 471 475
45. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, and D.R. Marshak Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
46. V. Santarlasci, L. Maggi, M. Capone, V. Querci, L. Beltrame, D. Cavalieri, E. D'Aiuto, R. Cimaz, A. Nebbioso, F. Liotta, and et al. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion Immunity 36 2012 201 214
47. Z. Selmani, A. Naji, I. Zidi, B. Favier, E. Gaiffe, L. Obert, C. Borg, P. Saas, P. Tiberghien, N. Rouas-Freiss, and et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells Stem Cells 26 2008 212 222
48. G. Shi, B.P. Vistica, L.F. Nugent, C. Tan, E.F. Wawrousek, D.M. Klinman, and I. Gery Differential involvement of Th1 and Th17 in pathogenic autoimmune processes triggered by different TLR ligands J. Immunol. 191 2013 415 423
49. J. Stagg, S. Pommey, N. Eliopoulos, and J. Galipeau Interferon-gamma-stimulated marrow stromal cells: A new type of nonhematopoietic antigen-presenting cell Blood 107 2006 2570 2577
50. T.L. Sumpter, and A.W. Thomson The STATus of PD-L1 (B7-H1) on tolerogenic APCs Eur. J. Immunol. 41 2011 286 290
51. L. Sun, K. Akiyama, H. Zhang, T. Yamaza, Y. Hou, S. Zhao, T. Xu, A. Le, and S. Shi Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans Stem Cells 27 2009 1421 1432
52. J. Tan, W. Wu, X. Xu, L. Liao, F. Zheng, S. Messinger, X. Sun, J. Chen, S. Yang, J. Cai, and et al. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: A randomized controlled trial JAMA 307 2012 1169 1177
53. S.L. Topalian, F.S. Hodi, J.R. Brahmer, S.N. Gettinger, D.C. Smith, D.F. McDermott, J.D. Powderly, R.D. Carvajal, J.A. Sosman, M.B. Atkins, and et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer N. Engl. J. Med. 366 2012 2443 2454
54. G.H. Tso, H.K. Law, W. Tu, G.C. Chan, and Y.L. Lau Phagocytosis of apoptotic cells modulates mesenchymal stem cells osteogenic differentiation to enhance IL-17 and RANKL expression on CD4+ T cells Stem Cells 28 2010 939 954
55. A. Uccelli, L. Moretta, and V. Pistoia Mesenchymal stem cells in health and disease Nat. Rev. Immunol. 8 2008 726 736
56. C.T. Weaver, and R.D. Hatton Interplay between the TH17 and TReg cell lineages: A (co-)evolutionary perspective Nat. Rev. Immunol. 9 2009 883 889
57. S.J. Wölfle, J. Strebovsky, H. Bartz, A. Sähr, C. Arnold, C. Kaiser, A.H. Dalpke, and K. Heeg PD-L1 expression on tolerogenic APCs is controlled by STAT-3 Eur. J. Immunol. 41 2011 413 424
58. J. Xu, D. Wang, D. Liu, Z. Fan, H. Zhang, O. Liu, G. Ding, R. Gao, C. Zhang, Y. Ding, and et al. Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome Blood 120 2012 3142 3151
59. B.L. Yen, H.I. Huang, C.C. Chien, H.Y. Jui, B.S. Ko, M. Yao, C.T. Shun, M.L. Yen, M.C. Lee, and Y.C. Chen Isolation of multipotent cells from human term placenta Stem Cells 23 2005 3 9
60. B.L. Yen, M.L. Yen, P.J. Hsu, K.J. Liu, C.J. Wang, C.H. Bai, and H.K. Sytwu Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3 Stem Cell Reports 1 2013 139 151
61. C. Zaph, Y. Du, S.A. Saenz, M.G. Nair, J.G. Perrigoue, B.C. Taylor, A.E. Troy, D.E. Kobuley, R.A. Kastelein, D.J. Cua, and et al. Commensal-dependent expression of IL-25 regulates the IL-23-IL-17 axis in the intestine J. Exp. Med. 205 2008 2191 2198
62. B. Zhou, J. Yuan, Y. Zhou, M. Ghawji Jr., Y.P. Deng, A.J. Lee, A.J. Lee, U. Nair, A.H. Kang, D.D. Brand, and T.J. Yoo Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis Clin. Immunol. 141 2011 328 337
63. C.E. Zielinski, F. Mele, D. Aschenbrenner, D. Jarrossay, F. Ronchi, M. Gattorno, S. Monticelli, A. Lanzavecchia, and F. Sallusto Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β Nature 484 2012 514 518
64. P.A. Zuk, M. Zhu, H. Mizuno, J. Huang, J.W. Futrell, A.J. Katz, P. Benhaim, H.P. Lorenz, and M.H. Hedrick Multilineage cells from human adipose tissue: Implications for cell-based therapies Tissue Eng. 7 2001 211 228